However, the use of the anti-IDH1 R132H antibody has its limitations; although most oligodendrogliomas and low-grade astrocytomas carry the IDH1 R132H mutation, other mutations occur in IDH1 or IDH2 genes [2,3] that cannot be detected with the antibody. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).